84 related articles for article (PubMed ID: 11025320)
1. Terbogrel, a dual-acting agent for thromboxane receptor antagonism and thromboxane synthase inhibition.
Michaux C; Norberg B; Dogné JM; Durant F; Masereel B; Delarge J; Wouters J
Acta Crystallogr C; 2000 Oct; 56 ( Pt 10)():1265-6. PubMed ID: 11025320
[TBL] [Abstract][Full Text] [Related]
2. N-tert-butyl-N'-(2-cyclohexylamino-5-nitrobenzenesulfonyl)urea, BM531, a dual-acting agent for thromboxane receptor antagonism and thromboxane synthase inhibition.
Michaux C; Dogné JM; Norberg B; Durant F; Masereel B
Acta Crystallogr C; 2002 Oct; 58(Pt 10):o621-3. PubMed ID: 12359948
[TBL] [Abstract][Full Text] [Related]
3. Structure determination and comparison of BM567, a sulfonylurea, with terbogrel, two compounds with dual action, thromboxane receptor antagonism and thromboxane synthase inhibition.
Michaux C; Rolin S; Dogné JM; Durant F; Masereel B; Delarge J; Wouters J
Bioorg Med Chem Lett; 2001 Apr; 11(8):1019-22. PubMed ID: 11327579
[TBL] [Abstract][Full Text] [Related]
4. Guanidine derivatives as combined thromboxane A2 receptor antagonists and synthase inhibitors.
Soyka R; Guth BD; Weisenberger HM; Luger P; Müller TH
J Med Chem; 1999 Apr; 42(7):1235-49. PubMed ID: 10197967
[TBL] [Abstract][Full Text] [Related]
5. Development of dual-acting agents for thromboxane receptor antagonism and thromboxane synthase inhibition. 3. Synthesis and biological activities of oxazolecarboxamide-substituted omega-phenyl-omega-(3-pyridyl)alkenoic acid derivatives and related compounds.
Takeuchi K; Kohn TJ; True TA; Mais DE; Wikel JH; Utterback BG; Wyss VL; Jakubowski JA
J Med Chem; 1998 Dec; 41(27):5362-74. PubMed ID: 9876106
[TBL] [Abstract][Full Text] [Related]
6. Development of dual-acting agents for thromboxane receptor antagonism and thromboxane synthase inhibition. 2. Design, synthesis, and evaluation of a novel series of phenyl oxazole derivatives.
Takeuchi K; Kohn TJ; Mais DE; True TA; Wyss VL; Jakubowski JA
Bioorg Med Chem Lett; 1998 Aug; 8(15):1943-8. PubMed ID: 9873463
[TBL] [Abstract][Full Text] [Related]
7. Dual-acting thromboxane receptor antagonist/synthase inhibitors: synthesis and biological properties of [2-substituted-4-(3-pyridyl)-1,3-dioxan-5-yl] alkenoic acids.
Faull AW; Brewster AG; Brown GR; Smithers MJ; Jackson R
J Med Chem; 1995 Feb; 38(4):686-94. PubMed ID: 7861416
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and pharmacodynamics of terbogrel, a combined thromboxane A2 receptor and synthase inhibitor, in healthy subjects.
Guth BD; Narjes H; Schubert HD; Tanswell P; Riedel A; Nehmiz G
Br J Clin Pharmacol; 2004 Jul; 58(1):40-51. PubMed ID: 15206991
[TBL] [Abstract][Full Text] [Related]
9. A novel approach to dual-acting thromboxane receptor antagonist/synthase inhibitors based on the link of 1,3-dioxane-thromboxane receptor antagonists and -thromboxane synthase inhibitors.
Ackerley N; Brewster AG; Brown GR; Clarke DS; Foubister AJ; Griffin SJ; Hudson JA; Smithers MJ; Whittamore PR
J Med Chem; 1995 May; 38(10):1608-28. PubMed ID: 7752186
[TBL] [Abstract][Full Text] [Related]
10. Effects of the thromboxane synthetase inhibitor and receptor antagonist terbogrel in patients with primary pulmonary hypertension.
Langleben D; Christman BW; Barst RJ; Dias VC; Galiè N; Higenbottam TW; Kneussl M; Korducki L; Naeije R; Riedel A; Simonneau G; Hirsch AM; Rich S; Robbins IM; Oudiz R; McGoon MD; Badesch DB; Levy RD; Mehta S; Seeger W; Solèr M
Am Heart J; 2002 May; 143(5):E4. PubMed ID: 12040360
[TBL] [Abstract][Full Text] [Related]
11. Thromboxane modulating agents. 3. 1H-imidazol-1-ylalkyl- and 3-pyridinylalkyl-substituted 3-[2-[(arylsulfonyl)amino]ethyl]benzenepropanoic acid derivatives as dual thromboxane synthase inhibitor/thromboxane receptor antagonists.
Dickinson RP; Dack KN; Long CJ; Steele J
J Med Chem; 1997 Oct; 40(21):3442-52. PubMed ID: 9341919
[TBL] [Abstract][Full Text] [Related]
12. On the bioisosteric potential of diazines: diazine analogues of the combined thromboxane A2 receptor antagonist and synthetase inhibitor Ridogrel.
Heinisch G; Holzer W; Kunz F; Langer T; Lukavsky P; Pechlaner C; Weissenberger H
J Med Chem; 1996 Sep; 39(20):4058-64. PubMed ID: 8831771
[TBL] [Abstract][Full Text] [Related]
13. ZD1542, a potent thromboxane A2 synthase inhibitor and receptor antagonist in vitro.
Brownlie RP; Brownrigg NJ; Butcher HM; Garcia R; Jessup R; Lee VJ; Tunstall S; Wayne MG
Br J Pharmacol; 1993 Dec; 110(4):1600-6. PubMed ID: 8306107
[TBL] [Abstract][Full Text] [Related]
14. The dual thromboxane receptor antagonist and thromboxane synthase inhibitor EV-077 is a more potent inhibitor of platelet function than aspirin.
Fontana P; Alberts P; Sakariassen KS; Bounameaux H; Meyer JP; Santana Sorensen A
J Thromb Haemost; 2011 Oct; 9(10):2109-11. PubMed ID: 21777369
[No Abstract] [Full Text] [Related]
15. Development of dual-acting agents for thromboxane receptor antagonism and thromboxane synthase inhibition--I. Synthesis, structure-activity relationship, and evaluation of substituted omega-phenyl-omega-(3-pyridyl)alkenoic acids.
Takeuchi K; Happ AM; Mais DE; Layman N; Utterback BG; Wyss VL; Jakubowski JA
Bioorg Med Chem; 1994 Aug; 2(8):743-55. PubMed ID: 7894968
[TBL] [Abstract][Full Text] [Related]
16. A pharmacophore model for sulphonyl-urea (-cyanoguanidine) compounds with dual action, thromboxane receptor antagonists and thromboxane synthase inhibitors.
Michaux C; Dogné JM; Rolin S; Masereel B; Wouters J; Durant F
Eur J Med Chem; 2003; 38(7-8):703-10. PubMed ID: 12932901
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of FCE 27262, a combined thromboxane synthase inhibitor and PGH2/TXA2 receptor antagonist.
Vaghi F; Colombo M; Pierucci L; Volpi D; Dho L; Ukmar G; Rosa B; Salvati P
Drugs Exp Clin Res; 1993; 19(6):249-60. PubMed ID: 8013268
[TBL] [Abstract][Full Text] [Related]
18. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation.
Vezza R; Nenci GG; Gresele P
J Pharmacol Exp Ther; 1995 Dec; 275(3):1497-505. PubMed ID: 8531121
[TBL] [Abstract][Full Text] [Related]
19. A comparative evaluation of thromboxane receptor blockade, thromboxane synthase inhibition and both in animal models of arterial thrombosis.
Salvati P; Dho L; Ukmar G; Vaga L; Rimoldi O; Patrono C
J Pharmacol Exp Ther; 1994 Apr; 269(1):238-45. PubMed ID: 8169831
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
Yu SM; Wu TS; Teng CM
Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
